Who starts antiretroviral therapy in Durban, South Africa?… not everyone who should

Objective:To evaluate rates of antiretroviral therapy (ART) initiation within 12 months of a new HIV diagnosis in Durban, South Africa. Design:Prospective observational cohort. Methods:Adults (≥18 years) were enrolled before HIV testing at two outpatient clinics into the South African Test, Identify and Link cohort. Both sites offer comprehensive HIV care. HIV test results, CD4 cell counts, dates of ART initiation and dates of death were collected from medical records and 12-month patient/family interviews were conducted. ART eligibility was defined as a CD4 cell count less than 200 cells/μl within 90 days of HIV diagnosis. The primary endpoint was ART initiation within 12 months for ART-eligible subjects. Results:From November 2006 to October 2008, 1474 newly diagnosed HIV-infected outpatients were enrolled, 1012 (69%) of whom underwent CD4 cell count testing within 90 days. The median CD4 cell count was 159 cells/μl (interquartile range 65–299). Of those who underwent CD4 cell count testing, 538 (53%) were ART-eligible. Only 210 (39%) eligible enrollees were known to have initiated ART within 12 months. Among ART-eligible subjects, there were 108 known deaths; 82% occurred before ART initiation or with unknown ART initiation status. Men [rate ratio (RR) 1.3, 95% confidence interval (CI) 1.1–1.5] and subjects without an HIV-infected family member/friend (RR 1.3, 95% CI 1.1–1.7) were more likely not to start ART. Conclusion:Less than half of ART-eligible subjects started ART within 12 months. Substantial attrition and mortality follow HIV diagnosis before ART initiation in Durban, South Africa. Major efforts directed towards earlier HIV diagnosis, effective linkage to care and timely ART initiation are urgently needed.

[1]  C. Wiysonge,et al.  Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review , 2007, BMC public health.

[2]  L. Myer,et al.  Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa , 2008, AIDS.

[3]  L. Myer,et al.  Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. , 2006, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[4]  J. Pfeiffer,et al.  Loss to Follow-Up of Adults in Public HIV Care Systems in Central Mozambique: Identifying Obstacles to Treatment , 2009, Journal of acquired immune deficiency syndromes.

[5]  J. Sterne,et al.  Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries , 2006, The Lancet.

[6]  R. Walensky,et al.  Routine Voluntary HIV Testing in Durban, South Africa: The Experience From an Outpatient Department , 2007, Journal of acquired immune deficiency syndromes.

[7]  E. N. Waddell,et al.  Social Support, Disclosure, and Use of Antiretroviral Therapy , 2006, AIDS and Behavior.

[8]  Sydney Rosen,et al.  Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review , 2007, PLoS medicine.

[9]  G. Maartens,et al.  Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa , 2004, AIDS.

[10]  N. Ford,et al.  Expanding HIV care in Africa: making men matter , 2009, The Lancet.

[11]  E. Bateman,et al.  Effectiveness of antiretroviral treatment in a South African program: a cohort study. , 2008, Archives of internal medicine.

[12]  Summary TOWARDS UNIVERSAL ACCESS : Scaling up Priority HIV / AIDS Interventions in the Health Sector Progress Report , 2008 .

[13]  L. Myer,et al.  Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. , 2008, Bulletin of the World Health Organization.

[14]  L. Myer,et al.  Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design , 2005, AIDS.

[15]  M. Egger,et al.  Mortality of Patients Lost to Follow-Up in Antiretroviral Treatment Programmes in Resource-Limited Settings: Systematic Review and Meta-Analysis , 2009, PloS one.

[16]  L. Myer,et al.  Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  N. Low,et al.  Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. , 2008, Journal of women's health.

[18]  R. Remien,et al.  The Role of HIV Serostatus Disclosure in Antiretroviral Medication Adherence , 2006, AIDS and Behavior.

[19]  R. Walensky,et al.  Loss to Care and Death Before Antiretroviral Therapy in Durban, South Africa , 2009, Journal of acquired immune deficiency syndromes.